CHELMSFORD, Mass., Nov. 22, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in two upcoming investor conferences:
- Credit Suisse 23rd Annual Technology Conference in Scottsdale, AZ on December 3, 2019 with a webcast beginning at 2:20 p.m. MST (4:20 p.m. EST).
- Evercore ISI 2nd Annual HealthCONx Conference in Boston, MA on December 5, 2019 with a webcast beginning at 9:30 a.m. EST.
The live audio webcasts can be accessed through the Investor Relations page of the Brooks Automation website at www.brooks.com. A replay of the presentations will be available following the events.
About Brooks Automation
Brooks is a leading provider of life science and semiconductor manufacturing automation solutions worldwide. The Company applies its automation and cryogenics expertise to provide a full suite of reliable cold-chain sample management solutions across life sciences in areas such as drug development, clinical research and advanced cell therapies. Brooks recently added global capability for gene sequencing and gene synthesis services through its strategic acquisition of GENEWIZ, expanding its sample-based services offerings. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision robotics, integrated automation systems and services. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, visit www.brooks.com.
INVESTOR CONTACTS:
Mark Namaroff
Director, Investor Relations
Brooks Automation
978.262.2635
mark.namaroff@brooks.com
Sherry Dinsmore
Brooks Automation
978.262.2400
sherry.dinsmore@brooks.com
John Mills
Senior Managing Director
ICR, LLC
646.277.1254
John.mills@icrinc.com
SOURCE Brooks Automation
